Average Co-Inventor Count = 6.00
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (8 from 1,974 patents)
2. Medarex Inc. (4 from 152 patents)
3. E. R. Squibb Sons, Inc. (1 from 1,624 patents)
8 patents:
1. 9260514 - Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
2. 8455629 - Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
3. 8367063 - Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
4. 8198410 - Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
5. 8106167 - Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
6. 7795413 - Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
7. 7718776 - Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
8. 7601818 - Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors